Japan Ophthalmic Devices Investment Opportunities

Analysis and Forecasts to 2012

Product Code GMD06531
Publication Date July 2008
Publisher Global Markets Direct
Product Type Report
Pages 86
ISBN Number not applicable
Change currency
PDF £1,895.00 €2,282 $2,996 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Japan Ophthalmic Devices Investment Opportunities

Analysis and Forecasts to 2012

Japan Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Japan ophthalmic devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the ophthalmic devices in Japan

Scope

  • The report provides ophthalmic devices information broken down into detailed categories and segments in Japan.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the ophthalmic devices market in Japan.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of the Markets Covered in the Report
    • 3.1 Ophthalmic Devices
    • 3.2 Cataract Surgery
      • 3.2.1 Phacoemulsification Equipment
      • 3.2.2 Intra Ocular Lens
    • 3.3 Vision Care
      • 3.3.1 Ophthalmoscopes
      • 3.3.2 Contact lenses
      • 3.3.3 Lens care
      • 3.3.4 Ophthalmic lens
      • 3.3.5 Rigid Gas Permeable Contact Lenses
    • 3.4 Refractive Surgery
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Market Authorization Holder (MAH)
      • 5.1.2 Classification and Pre-Market Approval of Medical Devices
      • 5.1.3 Third Party Certification for Controlled Medical Devices
      • 5.1.4 PMDA Approval for Highly Controlled Medical Devices
      • 5.1.5 Registration Time
      • 5.1.6 Registration Fee
      • 5.1.7 Post Marketing Surveillance
      • 5.1.8 Labeling and Packaging
  • 6 Pricing and Reimbursement
    • 6.1 Market Pricing
    • 6.2 Reimbursement Policies
    • 6.3 Reimbursement Classes
      • 6.3.1 Class A
      • 6.3.2 Class B
      • 6.3.3 Class C
      • 6.3.4 Class F
    • 6.4 Request for Reimbursement
    • 6.5 Reduction in Reimbursement for Medical Devices and Drugs
  • 7 Distribution Structure
  • 8 Japan Medical Equipment Cross Market Comparison
  • 9 Ophthalmic Devices Cross Country Comparison
  • 10 Ophthalmic Devices in Japan
    • 10.1 Ophthalmic Devices Overall Revenues by Category (2000-2012)
    • 10.2 Ophthalmic Devices Overall Volume by Category (2000-2012)
    • 10.3 Ophthalmic Devices Overall Company Share (2006-2007)
  • 11 Vision Care in Japan
    • 11.1 Vision Care Revenues by Segment (2000-2012)
    • 11.2 Vision Care Volume by Segment (2000-2012)
    • 11.3 Vision Care Average Price (2000-2012)
    • 11.4 Vision Care Distribution Share (2006-2007)
    • 11.5 Vision Care Company Share (2006-2007)
  • 12 Cataract Surgery in Japan
    • 12.1 Cataract Surgery Revenues by Segment (2000-2012)
    • 12.2 Cataract Surgery Volume by Segment (2000-2012)
    • 12.3 Cataract Surgery Average Price (2000-2012)
    • 12.4 Cataract Surgery Distribution Share (2006-2007)
    • 12.5 Cataract Surgery Company Share (2006-2007)
  • 13 Refractive Surgery in Japan
    • 13.1 Refractive Surgery Revenues (2000-2012)
    • 13.2 Refractive Surgery Volume (2000-2012)
    • 13.3 Refractive Surgery Average Price (2000-2012)
    • 13.4 Refractive Surgery Distribution Share (2006-2007)
    • 13.5 Refractive Surgery Company Share (2006-2007)
  • 14 Ajinomoto Trading, Inc. Company Review
    • 14.1 Company Overview
  • 15 Alcon, Inc. Company Profile
    • 15.1 Company Overview
    • 15.2 Value Chain Analysis
      • 15.2.1 Manufacturing
        • 15.2.1.1 In House Manufacturing
        • 15.2.1.2 Outsourcing
      • 15.2.2 Product Development
        • 15.2.2.1 Regulatory Approvals
        • 15.2.2.2 Clinical Trials
        • 15.2.2.3 Research and Development
      • 15.2.3 Sales and Marketing
        • 15.2.3.1 Partnerships and Alliances
        • 15.2.3.2 Licensing Agreements
    • 15.3 Alcon, Inc. Pipeline Products
      • 15.3.1 Alcon, Inc. Pipeline Products by Equipment Type
      • 15.3.2 Alcon, Inc. Pipeline Products by Development Stage
      • 15.3.3 Alcon, Inc. Pipeline Products by Therapy Area
      • 15.3.4 Alcon, Inc. Pipeline Products by Clinical Trials
  • 16 CIBA Vision Corporation Company Profile
    • 16.1 Company Overview
    • 16.2 CIBA Vision Corporation Pipeline Products
      • 16.2.1 CIBA Vision Corporation Pipeline Products by Equipment Type
      • 16.2.2 CIBA Vision Corporation Pipeline Products by Development Stage
      • 16.2.3 CIBA Vision Corporation Pipeline Products by Therapy Area
      • 16.2.4 CIBA Vision Corporation Pipeline Products by Clinical Trials
  • 17 Essilor International Company Profile
    • 17.1 Company Overview
    • 17.2 Value Chain Analysis
      • 17.2.1 Manufacturing
        • 17.2.1.1 In House Manufacturing
      • 17.2.2 Product Development
        • 17.2.2.1 Regulatory Approvals
        • 17.2.2.2 Research and Development
      • 17.2.3 Sales and Marketing
        • 17.2.3.1 Partnerships and Alliances
  • 18 Hamamatsu Photonics K.K Company Review
    • 18.1 Company Overview
  • 19 Hoya Corporation Company Profile
    • 19.1 Company Overview
    • 19.2 Value Chain Analysis
      • 19.2.1 Manufacturing
        • 19.2.1.1 In House Manufacturing
        • 19.2.1.2 Outsourcing
      • 19.2.2 Product Development
        • 19.2.2.1 Regulatory Approvals
        • 19.2.2.2 Research and Development
      • 19.2.3 Sales and Marketing
        • 19.2.3.1 Partnerships and Alliances
        • 19.2.3.2 Licensing Agreements
        • 19.2.3.3 E-distribution
  • 20 Johnson & Johnson Vision Care, Inc. Company Profile
    • 20.1 Company Overview
  • 21 SEIKO OPTICAL PRODUCTS CO., LTD. Company Profile
    • 21.1 Company Overview
  • 22 Financial Deals Landscape
    • 22.1 Acquisition
      • 22.1.1 HOYA Acquires PENTAX
      • 22.1.2 STAAR Surgical Acquires Canon Staar From Canon And Canon Marketing Japan
  • 23 Appendix
    • 23.1 Global Markets Direct Research Methodology
    • 23.2 Coverage
    • 23.3 Secondary Research
    • 23.4 Primary Research
    • 23.5 Models
    • 23.6 Forecasts
    • 23.7 Expert Panels
    • 23.8 Currency Conversion
    • 23.9 Contact Us
    • 23.10 Disclaimer
    • 1.1 List of Tables
    • Table 1: Healthcare Expenditure in Japan, 2000 - 2005
    • Table 2: Number of Healthcare Institutions in Japan, 1995 - 2004
    • Table 3: Number of Hospital Beds in Japan, 1995 - 2004
    • Table 4: Number of Medical Personnel in Japan, 1995 - 2004
    • Table 5: Number of Doctors by Specialty in Japan, 2003-2007
    • Table 6: Number of Medical Care Institutions and Beds in Japan, 2000 - 2004
    • Table 7: Registration Processing Time for Medical Devices in Japan, 2007
    • Table 8: Product Registration Fee for Medical Devices in Japan, 2007
    • Table 9: Japan, Medical Equipment Market Comparison
    • Table 10: Ophthalmic Devices, Revenues ($ mn) by Country, 2000-2012
    • Table 11: Ophthalmic Devices, Japan, Category Revenues ($ mn), 2000-2012
    • Table 12: Ophthalmic Devices Market, Japan, Portfolio Analysis
    • Table 13: Ophthalmic Devices, Japan, Category Revenues ($ mn), Historic, 2000-2007
    • Table 14: Ophthalmic Devices, Japan, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 15: Ophthalmic Devices, Japan, Category Volume (Units), 2000-2012
    • Table 16: Ophthalmic Devices, Japan, Category Volume (Units), Historic, 2000-2007
    • Table 17: Ophthalmic Devices, Japan, Category Volume (Units), Forecast, 2007-2012
    • Table 18: Ophthalmic Devices, Japan, Overall Company Share by Revenue, 2006-2007
    • Table 19: Vision Care, Japan, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 20: Vision Care, Japan, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 21: Vision Care, Japan, Volume (Units) by Segment, Historic, 2000-2007
    • Table 22: Vision Care, Japan, Volume (Units) by Segment, Forecast, 2007-2012
    • Table 23: Vision Care, Japan, Average Price ($), Historic, 2000-2007
    • Table 24: Vision Care, Japan, Average Price ($), Forecast, 2007-20012
    • Table 25: Vision Care, Japan, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 26: Vision Care, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 27: Cataract Surgery, Japan, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 28: Cataract Surgery, Japan, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 29: Cataract Surgery, Japan, Volume (Units) by Segment, Historic, 2000-2007
    • Table 30: Cataract Surgery, Japan, Volume (Units) by Segment, Forecast, 2007-2012
    • Table 31: Cataract Surgery, Japan, Average Price ($), Historic, 2000-2007
    • Table 32: Cataract Surgery, Japan, Average Price ($), Forecast, 2007-2012
    • Table 33: Cataract Surgery, Japan, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 34: Cataract Surgery, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 35: Refractive Surgery, Japan, Revenues ($ mn), Historic, 2000-2007
    • Table 36: Refractive Surgery, Japan, Revenues ($ mn), Forecast, 2007-2012
    • Table 37: Refractive Surgery, Japan, Volume (Units), Historic, 2000-2007
    • Table 38: Refractive Surgery, Japan, Volume (Units), Forecast, 2007-2012
    • Table 39: Refractive Surgery, Japan, Average Price ($), Historic, 2000-2007
    • Table 40: Refractive Surgery, Japan, Average Price ($), Forecast, 2007-2012
    • Table 41: Refractive Surgery, Japan, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 42: Refractive Surgery, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 43: Alcon, Inc. Pipeline Products by Equipment Type
    • Table 44: Alcon, Inc. Pipeline Products By Development Stage
    • Table 45: Alcon, Inc. Pipeline Products By Therapy Area
    • Table 46: Alcon, Inc. Pipeline Products By Clinical Trials
    • Table 47: CIBA Vision Corporation Pipeline Products by Equipment Type
    • Table 48: CIBA Vision Corporation Pipeline Products By Development Stage
    • Table 49: CIBA Vision Corporation Pipeline Products By Therapy Area
    • Table 50: CIBA Vision Corporation Pipeline Products By Clinical Trials
    • Table 51: Currency Conversion from USD to Local Currency at 2007 Constant Rate
    • 1.2 List of Figures
    • Figure 1: Healthcare Expenditure in Japan, 2000 - 2005
    • Figure 2: Government and Private Healthcare Expenditure in Japan, 2005
    • Figure 3: Medical Device Classification in Japan, 2007
    • Figure 4: Approval Process for Controlled Medical Devices in Japan, 2007
    • Figure 5: Approval Process for Highly Controlled Medical Devices in Japan, 2007
    • Figure 6: Health Insurance Reimbursement Process in Japan, 2007
    • Figure 7: Distribution Structure for Medical Equipment in Japan, 2007
    • Figure 8: Japan, Medical Equipment Market Comparison, 2007
    • Figure 9: Ophthalmic Devices, Revenues ($ mn) by Country, 2000-2012
    • Figure 10: Ophthalmic Devices Market, Country Comparison
    • Figure 11: Ophthalmic Devices, Japan, Category Revenues ($ mn), 2000-2012
    • Figure 12: Ophthalmic Devices Market, Japan, Portfolio Analysis
    • Figure 13: Ophthalmic Devices, Japan, Category Revenues ($ mn), Historic, 2000-2007
    • Figure 14: Ophthalmic Devices, Japan, Category Revenues ($ mn), Forecast, 2007-2012
    • Figure 15: Ophthalmic Devices, Japan, Overall Company Share (%), 2007
    • Figure 16: Vision Care, Japan, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 17: Vision Care, Japan, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 18: Vision Care, Japan, Company Share (%), 2007
    • Figure 19: Cataract Surgery, Japan, Revenue by Segment ($ mn), Historic, 2000-2007
    • Figure 20: Cataract Surgery, Japan, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Figure 21: Cataract Surgery, Japan, Company Share (%), 2007
    • Figure 22: Refractive Surgery, Japan, Revenues ($ mn), Historic, 2000-2007
    • Figure 23: Refractive Surgery, Japan, Revenues ($ mn), Forecast, 2007-2012
    • Figure 24: Refractive Surgery, Japan, Volume (Units), Historic, 2000-2007
    • Figure 25: Refractive Surgery, Japan, Volume (Units), Forecast, 2007-2012
    • Figure 26: Refractive Surgery, Japan, Company Share (%), 2007
    • Figure 27: Alcon, Inc., Value Chain Analysis
    • Figure 28: Essilor International, Value Chain Analysis
    • Figure 29: Hoya Corporation, Value Chain Analysis
    • Figure 30: Global Markets Direct Methodology